1WA
ALT icon

180 Wealth Advisors’s Altimmune ALT Stock Holding History

180 Wealth Advisors’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,300
Closed -$43.7K – 456
2025
Q2 		$43.7K Sell
11,300
-775
-6% -$4.19K 0.01% 423
2025
Q1 		$60.4K Buy
12,075
+1,220
+11% +$7.73K 0.01% 405
2024
Q4 		$78.3K Buy
+10,855
New +$82.9K 0.01% 417

Other funds holding ALT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

180 Wealth Advisors's ALT Position: Q3 2025 in Review

180 Wealth Advisors sold out of Altimmune (ALT) in Q3 2025, closing a stake of 11,300 shares — an estimated $43.7K sold.

180 Wealth Advisors first reported a position in ALT in Q4 2024 and held it in 3 quarters. The position peaked at $78.3K in Q4 2024. 158 funds tracked by Wall St. Rank hold ALT as of Q3 2025.

  • 180 Wealth Advisors reported no remaining Altimmune position as of Q3 2025 after selling out during the quarter.
  • 180 Wealth Advisors sold 11,300 Altimmune shares in Q3 2025, an estimated $43.7K.
  • 180 Wealth Advisors first reported a position in Altimmune in Q4 2024 and held it in 3 quarters.
  • 180 Wealth Advisors's Altimmune position peaked at $78.3K in Q4 2024.
  • 158 funds tracked by Wall St. Rank held Altimmune as of Q3 2025.

Based on 180 Wealth Advisors's 13F filing for Q3 2025, filed 16 Oct 2025.